Filing Flows › Myomo (MYO) › Q2 2026 › vs Q2 2025
Myomo (MYO) Q2 2026 vs Q2 2025 (year over year)
Myomo's revenue rose $2.1M (+21%) from $9.7M in Q2 2025 to $11.7M in Q2 2026.
Myomo, Q2 2026: revenue $11.7M (+21% year over year), operating margin -19.3%, net loss $4.0M, operating cash flow −$1.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $11.7M | $9.7M | $2.1M | +21% |
| Net loss | $4.0M | $4.6M | −$611K | -13% |
| Costs & expenses | $15.7M | $14.4M | $1.3M | +9% |
| Operating costs | $14.0M | $14.2M | −$284K | -2% |
| Interest & other, net | $1.7M | −$107K | $1.8M | — |
| Income tax | $31K | $148K | −$117K | -79% |
| Cost of revenue | $3.3M | $3.6M | −$338K | -9% |
| Research & development | $1.7M | $2.0M | −$281K | -14% |
| Sales & marketing | $5.3M | $5.2M | $30K | +0.6% |
| General & admin | $3.7M | $3.4M | $305K | +9% |
| Operating cash sources | $4.0M | $4.6M | −$611K | -13% |
| Depreciation & amortization | $385K | $191K | $194K | +102% |
| Share-based compensation | $1.0M | $395K | $648K | +164% |
| Working capital & other | $650K | −$4.8M | $5.5M | — |
| Cash used in operations | $1.9M | $8.9M | −$6.9M | -78% |
| Net loss absorbed | $4.0M | $4.6M | −$611K | -13% |
Questions
How much did Myomo's revenue grow year over year in Q2 2026?
Myomo's revenue rose $2.1M (+21%) from $9.7M in Q2 2025 to $11.7M in Q2 2026.